Bioplatform company builder Flagship Pioneering has announced its companies Ampersand Biomedicines and Montai Therapeutics ...

Ascentage Pharma's BCL-2 inhibitor, lisaftoclax, is under China’s Priority Review for chronic lymphocytic leukemia and small ...

Sweden-based Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development ...

A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry ...

US pharma giant Pfizer (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the ...

Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA).

California, USA-based biotech Cytokinetics saw its shares fall as much as 4% to $9.67 yesterday, after it announced a deal ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) ...

Samsung Biologics has secured a $668 million manufacturing agreement with a European pharma, bringing its total deals for the ...

Johnson & Johnson and Protagonist Therapeutics announced positive Phase III results for icotrokinra, an oral IL-23 targeting ...

Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). A ...

The UK’s health technology assessor the Institute for Health and Clinical Excellence (NICE) says that talks with the makers ...